Solid Tumor

The Archer® FusionPlex Solid Tumor panel is a robust targeted sequencing assay to simultaneously detect and identify fusions and other mutations associated with over 50 genes linked to various carcinomas. This panel uses Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment to detect all fusions associated with the genes in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.
Key Features
Comprehensive fusion detection

Identify hundreds of known and novel translocations simultaneously.

Efficient, lyophilized workflow

Reduce turn-around time and eliminate reflex testing.

Sample versatility

Works with all clinical sample types, including FFPE.


Add targets without sacrificing performance.

Specifications and Performance


Gene Targets

≥ 10ng

Input Nucleic Acid Required*

> 92%

Unique Molecular On-Target %

2.5 hours

Hands-on Time

9 hours

Total Time

Illumina and
Ion Torrent


Fresh Frozen or FFPE

Sample Types

*Input recommendations for FFPE samples vary depending on Archer PreSeq® RNA QC score; 50ng input recommended in absence of PreSeq screening

Gene Targets


Fusion, splicing or exon-skipping

NeeD to Modify Your Panel?

Add any of our wet lab-validated designs to this panel with Archer Assay Designer to build an assay that fits your exact requirements.

  • Find Your Fit

This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.

We won’t track your information when you visit our site. But in order to comply with your preferences, we’ll have to use just one tiny cookie so that you’re not asked to make this choice again.